IPO-V2: a prospective, multicenter, randomized, comparative clinical investigation of the effects of sulodexide in preventing cardiovascular accidents in the first year after acute myocardial infarction. [electronic resource]
- Journal of the American College of Cardiology Jan 1994
- 27-34 p. digital
Aged Cardiovascular Diseases--prevention & control Cause of Death Female Glycosaminoglycans--therapeutic use Heart Diseases--prevention & control Humans Hypolipidemic Agents--therapeutic use Male Middle Aged Myocardial Infarction--drug therapy Prospective Studies Recurrence Thrombolytic Therapy Thrombosis--prevention & control Time Factors